California has sent cease-and-desist letters to firms offering Web gene tests to consumers. The legal reason is that California law requires a licenced physician to order any lab tests. This follows from a similar crackdown in New York. Wired responds by top 10 reasons that regulators should not hinder genetic testing. Is there any good reason to limit public access to genetic testing besides protecting incumbents and gatekeepers?
Continue reading "My Genes, not a Doctor's" »
Drug company Merck and its product Vioxx are in the news again. An article in the Journal of the American Medical Association (JAMA) has examined the documents from the legal proceedings against Merck in connection with the withdrawal of Vioxx from the market in 2004. From their analysis, a significant number of journal articles – mostly review articles rather than articles reporting clinical trials – were written in-house and senior academics were brought in late to be lead named author. At least one of these academics has disputed the accusations made in the JAMA article.
Continue reading "Academic Integrity and Vioxx" »
Alcohol abuse in the UK has been escalating for decades, contributing to crime, unemployment, illness and death. Last month, the government reported that alcohol-related deaths in the UK have doubled over the last 15 years to almost 9,000. One prominent factor in these increases is the price of alcohol, which has remained relatively stable despite increases in income over the years, and has thus become much cheaper in real terms. The cheaper it is, the more of it people consume, and the more ill effects are felt. The British Medical Association has thus called on the government to prohibit the cheap sale of alcohol, and in a surprising turn of events, the dominant supermarket chain, Tesco, has echoed this call.
Continue reading "The perils of cheap alcohol" »
Recent Comments